Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Bovine colostrum composite powder

A technology of compound powder and colostrum, applied in dairy products, applications, milk preparations, etc., can solve problems such as malnutrition in chronic patients, and achieve the effects of improving intestinal health, reducing blood lipids, and preventing atherosclerosis

Pending Publication Date: 2020-11-27
SHANGHAI TIANLONG BIOTECH CO LTD
View PDF4 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] In order to solve the problem that existing products cannot solve postoperative or chronic patient malnutrition, the purpose of this invention is to provide a kind of bovine colostrum compound powder

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Bovine colostrum composite powder

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0060] A bovine colostrum compound powder, comprising the following components in parts by weight: 15 parts of soybean protein isolate powder, 3.1 parts of phospholipid powder, 15 parts of concentrated whey protein powder, 15.7 parts of isolated whey protein powder, 1.57 parts of bovine colostrum powder 2.81 parts of marine fish oligopeptide powder, 6.27 parts of inulin, 9 parts of maltodextrin, 10.45 parts of linseed oil microcapsule powder, 9.35 parts of fructooligosaccharide, and 0.06 part of steviol glycoside, of which linseed oil microcapsule powder contains Flaxseed oil, galacto-oligosaccharides, modified starch, silicon dioxide, fatty acid monoglycerides, fatty acid diglycerides, and sodium ascorbate.

Embodiment 2

[0062] A bovine colostrum compound powder, comprising the following components in parts by weight: 17 parts of soybean protein isolate powder, 3.1 parts of phospholipid powder, 16 parts of concentrated whey protein powder, 15.8 parts of isolated whey protein powder, 1.6 parts of bovine colostrum powder 3.4 parts of marine fish oligopeptide powder, 6.6 parts of inulin, 10 parts of maltodextrin, 9.9 parts of linseed oil microcapsule powder, 8.8 parts of fructooligosaccharide, and 0.057 part of steviol glycoside, of which linseed oil microcapsule powder contains Flaxseed oil, galacto-oligosaccharides, modified starch, silicon dioxide, fatty acid monoglycerides, fatty acid diglycerides, and sodium ascorbate.

Embodiment 3

[0064] A bovine colostrum compound powder, comprising the following components in parts by weight: 16 parts of soybean protein isolate powder, 3.1 parts of phospholipid powder, 17.5 parts of concentrated whey protein powder, 18.37 parts of isolated whey protein powder, 1.73 parts of bovine colostrum powder 3.3 parts of marine fish oligopeptide powder, 6.93 parts of inulin, 10.5 parts of maltodextrin, 11.55 parts of linseed oil microcapsule powder, 11.55 parts of fructooligosaccharide, and 0.48 part of steviol glycoside, of which linseed oil microcapsule powder contains Flaxseed oil, galacto-oligosaccharides, modified starch, silicon dioxide, fatty acid monoglycerides, fatty acid diglycerides, and sodium ascorbate.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a bovine colostrum composite powder. The powder comprises the following components in parts by weight: 15-20 parts of soybean protein isolate powder, 3.1-3.8 parts of phospholipid powder, 15-19.21 parts of whey protein concentrate powder, 15.7-18.37 parts of whey protein isolate powder, 1.57-2.15 parts of bovine colostrum powder, 2.81-4.13 parts of marine fish oligopeptidepowder, 6.27-7.92 parts of inulin, 9-11.5 parts of maltodextrin, 9.9-13.2 parts of flaxseed oil microcapsule powder, 8.8-12.65 parts of fructo-oligosaccharide and 0.048-0.072 part of stevioside, wherein the flaxseed oil microcapsule powder comprises flaxseed oil, galactooligosaccharide, modified starch, silicon dioxide, monoglycerol fatty acid ester, diglycerol fatty acid ester and sodium ascorbate. According to the bovine colostrum composite powder disclosed by the invention, the four proteins of the whey protein isolate powder, the whey protein concentrate powder, the marine fish oligopeptide and the soybean protein isolate powder are combined for use, animal and plant proteins have a synergistic effect, various nutrient substances required by a human body can be comprehensively supplemented, the human body is helped to synthesize more immune globulins, and the composite powder directly supplements the immune globulins with the bovine colostrum powder, and helps chronic patients andpostoperative patients to improve the immunocompetence.

Description

technical field [0001] The invention relates to the technical field of dairy products, in particular to a bovine colostrum compound powder. Background technique [0002] Postoperative and chronic patients are special populations, and their basal metabolic rate is quite different from normal population. Postoperative and chronic patients are extremely prone to malnutrition. Reasons for malnutrition in postoperative or chronic patients: 1) The patient is highly stressed, hypermetabolized, or most of the patient’s own metabolism is partially impaired, which often puts the body in a state of negative nitrogen balance; 2) Patients often suffer from loss of appetite and metabolic disorders , decreased digestive function and other problems, affecting the normal digestion and absorption of food or certain nutrients in the gastrointestinal tract, resulting in malnutrition in patients. The impact of malnutrition on chronic diseases and postoperative recovery: 1) abnormal cell metabo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A23C9/16A23C9/152A23C9/156A23C9/158
CPCA23C9/16A23C9/152A23C9/1522A23C9/1526A23C9/1528A23C9/156A23C9/158
Inventor 何颖
Owner SHANGHAI TIANLONG BIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products